NICE Lessons On What To Expect from U.S. Comparative Effectiveness
Executive Summary
Costs appear to be an almost inevitable part of the expanded federal comparativeness research program, and the UK's 10-year old cost-effectiveness watchdog, the National Institute of Clinical Excellence, offers strategic clues for how the U.S. biopharma industry should respond, experts from the law firm Sidley Austin law firm advise
You may also be interested in...
Sen. Finance Republicans Press Sebelius On Comparative Effectiveness
Senate Finance Committee Republicans pressed HHS Secretary-designate Kathleen Sebelius to commit to keeping cost out of comparative effectiveness research, but she sidestepped directly giving her views on what role cost comparisons should play in comparative effectiveness research
NIH’s Comparative Effectiveness Plan Includes Some Studies Of “Cost Effectiveness”
NIH releases list of specific topics it would like researchers to study using its comparative effectiveness research funding.
AHRQ’s Clancy, OMB’s Emanuel Key Figures On Comparative Research Cmte.
The Federal Coordinating Committee on Comparative Effectiveness Research includes Agency for Health Care Research & Quality Administrator Carolyn Clancy and Office of Management & Budget Special Advisor Ezekiel Emanuel